Summary
Charalampos Lazaris is a Senior Expert in Oncology Data Science at Novartis with a decade of experience at the intersection of molecular biology, computational genomics, and cancer epigenetics. He combines deep academic training—PhD work on 3D genome organization at NYU and advanced bioinformatics MSc coursework—with hands-on translational science from roles at the Broad Institute, Whitehead Institute, and precision oncology at USC. His work focuses on nuclear organization and transcriptional dysregulation in cancer, applying computational methods to unravel epigenetic mechanisms and inform therapeutic strategies. Known for bridging rigorous research and industry-scale data science, he brings both wet-lab sensibility and computational rigor to oncology problems. A less obvious strength is his business training (MBA) and continuing education in drug discovery, which help him translate complex biological insights into actionable programs.
10 years of coding experience
5 years of employment as a software developer
Master of Business Administration - MBA, Master of Business Administration - MBA at Quantic School of Business and Technology
BSc Biology, BSc Biology at University of Ioannina
Master of Science (MSc) Bioinformatics, Master of Science (MSc) Bioinformatics at The University of Edinburgh
Research Doctorate Systems and Computational Biomedicine, Research Doctorate Systems and Computational Biomedicine at New York University
Other; HMX Pro online certificate program - Pharmacology-Drug Discovery and Development, Other; HMX Pro online certificate program - Pharmacology-Drug Discovery and Development at Harvard Medical School
MSc Molecular Biology, MSc Molecular Biology at University of Crete
Certificate of Achievement, Certificate of Achievement at Harvard Medical School Professional, Corporate, and Continuing Education
English, Greek